BiotiCorp / BIOTICORP

Page Under Construction### Full History of BiotiCorp Limited

#### Founding (2912 CE)
BiotiCorp Limited was founded in 2912 by Dr. Ted Santos and Dr. Diyo Nikolas, two doctoral students at the Scaliger School of Medicine in the Rhetor system. The two met in the renowned “Decon” lab while researching quantum travel’s effects on surgical robotics and genetic gravitational compression. Their groundbreaking collaboration revealed critical flaws in quantum travel’s impact on emergency surgeries, leading to protocol changes in Search and Rescue operations.

Recognizing the commercial and scientific value of their discovery, the Scaliger School of Medicine invested in a private research center, giving rise to BiotiCorp. Their first product, a software suite for surgical robots, reduced patient fatalities during quantum travel, securing early success and funding further innovations.

—-

#### Early Growth and Reputation (2913–2935)
BiotiCorp rapidly reinvested its profits into R&D, establishing itself as a pioneer in medical technology. Its AutoDoc series, launched in 2921, became the go-to surgical assist robot for both civilian and military use due to its reliability in harsh conditions.

In 2935, the company introduced the Vitalus Pro MediScan, a portable medical scanner capable of detailed diagnostics, earning critical acclaim but sparking debates on privacy due to its advanced capabilities. Despite controversies, the product became a staple in medical facilities across UEE space.

—-

#### Setbacks and Recovery (2924)
The PurLyfe anti-contamination chamber, released in 2924, aimed to prevent cross-contamination at planetary customs. However, its aggressive decontamination protocols inadvertently removed beneficial microbes, leading to widespread illness. After a public backlash, BiotiCorp issued a massive recall and implemented swift corrective measures, retaining public trust with their transparent handling of the crisis.

—-

#### Expansion into Reconstruction and Aesthetic Medicine (2935–2950)
BiotiCorp initiated Project Calliope in 2935, spearheaded by Chief Medical Engineer Dr. Livia Haskel. Drawing from personal experiences, Dr. Haskel developed a revolutionary system for reconstructive and cosmetic surgery. The project culminated in a device capable of comprehensive body alterations in a fraction of the time traditional surgery required.

Initially trialed in military applications, Calliope garnered praise for its life-changing impact, paving the way for civilian use. This innovation cemented BiotiCorp’s reputation as a transformative force in medical science.

—-

#### The Legal Overtake (2956)
In 2956, BiotiCorp became embroiled in a legal and financial crisis following allegations of intellectual property theft involving a competitor. A UEE tribunal investigated claims that BiotiCorp’s Calliope system incorporated unauthorized proprietary algorithms. Although cleared of wrongdoing, the trial revealed internal financial mismanagement, exposing the company to hostile acquisition attempts.

LEVIATHAN, a controversial combat scientist and entrepreneur, seized the opportunity. Utilizing a complex series of stock acquisitions, LEVIATHAN orchestrated a legal takeover of BiotiCorp. By the end of 2956, LEVIATHAN officially owned BiotiCorp Limited, introducing significant changes to its leadership and operations.

—-

#### Modern Era (2957–Present)
Under LEVIATHAN’s leadership, BiotiCorp expanded its focus beyond traditional medical devices, integrating combat-ready medical systems and enhancements designed for high-stakes environments. The company now balances its reputation for cutting-edge medical technology with LEVIATHAN’s militarized vision, serving both civilian and military sectors.

Today, BiotiCorp operates from a state-of-the-art facility in Reisse, continuing to innovate in diagnostic systems, surgical robotics, and human enhancement technologies. Despite its complex history, BiotiCorp remains a symbol of resilience and progress in the medical industry across UEE space. . Please check back soon!